Myriad Genetics, Inc. · NASDAQ:MYGN
Davis Mark Steven sold 6,100 Myriad Genetics, Inc. shares (Form 4)
Traded Nov 18, 2026 · Filed Nov 19, 2026
On Nov 18, 2026, Davis Mark Steven (Director) sold 6,100 Myriad Genetics, Inc. shares at US$5.62 for US$34,252, leaving 100,565 shares. Filed Nov 19, 2026 (Form 4).
- Sold
- 6,100 shares
- Price
- US$5.62
- Value
- US$34,252
- Holding after
- 100,565 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 18, 2026 | Common Stock | Sale | 6,100 | US$5.62 | 100,565 | Direct |
Source
Download original · View original at SEC
Related
- Myriad Genetics, Inc.
- Davis Mark Steven
- Myriad Genetics, Inc. shareholders
- Form 4 · Davis Mark Steven · Jun 5, 2026
- Schedule 13G/A · Vestal Point Capital, LP · Nov 16, 2026
- Form 4 · Fox Jennifer Lynne · Nov 2, 2026
- Schedule 13G/A · BlackRock Portfolio Management LLC · Oct 27, 2026
- Form 4 · Wheeler Benjamin Richard · Sep 22, 2026
- Form 4 · Sikri Vishal · Sep 17, 2026